Williams Jones Wealth Management, Llc. Northwest Biotherapeutics Inc Transaction History
Williams Jones Wealth Management, Llc.
- $8.37 Billion
- Q3 2024
A detailed history of Williams Jones Wealth Management, Llc. transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 35,000 shares of NWBO stock, worth $9,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,000
Previous 35,000
-0.0%
Holding current value
$9,100
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NWBO
# of Institutions
13Shares Held
674KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC462KShares$120,1750.02% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,6390.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,1620.0% of portfolio
-
Mai Capital Management20KShares$5,2000.0% of portfolio
-
Lee Danner & Bass Inc20KShares$5,2000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $270M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...